
Snake venom is a fairly complex mixture of proteins, oligopeptides and venom peptides that are delivered through fangs or grooved teeth. Venom varies a lot between species, both in composition and function. Some common toxins in snake venom include neurotoxins, which target the nervous system, hemotoxins that affect blood and cardiovascular systems, and myotoxins that damage muscle tissue. Venom serves mainly for prey immobilization or defense against predators, with most systems optimized for rapid incapacitation of targets with minimal expenditure of venom.
How Anti-Venom Works
When a snake bites someone, its venom is injected into the body through the bite wounds. The venom then circulates in the bloodstream and attacks different organ systems. Anti-Venom works by neutralizing the effects of snake venom already in the body. It contains antibodies produced in horses or sheep that are exposed to small, repeated, non-lethal doses of venom. These antibodies attach themselves to venom molecules, rendering them inactive. Once blood is removed from a victim, Anti-Venom antibodies are added to it. The antibodies then bind to any circulating venom, preventing it from binding to and damaging tissues and cells. This process neutralizes the venom and reverses its harmful effects.
Types of Anti-Venom Available
There are different types of anti- venom produced based on the type of snake involved in the bite. Some examples include:
- Polyvalent anti venoms: Contain antibodies against venom from multiple snake species found in a geographic region. This type is ideal for areas with multiple snake species.
- Monovalent anti venoms: Target venom from a single snake species. These are more specific but need to match the exact snake species involved to be effective.
- Bivalent anti venoms: Include antibodies against two main venomous snake species in a region. Examples are cobra-krait and Russell's viper-saw-scaled viper anti venoms.
- Freeze-dried anti venoms: Are stable at room temperature and easy to transport to remote areas. They just need rehydration before use.
- Lyophilized anti venoms: Go through a freeze-drying process to maximize shelf life at ambient temperatures without refrigeration.
Snake anti-venom supply and varies greatly worldwide depending on geographical location, prevalent venomous snakes, funding and other factors. Healthcare providers need to stock the right types based on local needs.
Administration and Effectiveness of Anti-Venom
Here are the standard steps involved in anti-venom administration:
- Clean and immobilize the bitten limb to reduce venom spread. Apply a pressure bandage or tourniquet above the bite.
- Administer 1-4 or more vials of anti-venom intravenously depending on severity of symptoms, victim age/weight and time since bite.
- Monitor for potential adverse reactions to Anti-Venom like anaphylaxis. Administer epinephrine and other treatment if needed.
- Continue monitoring vital signs and administer additional Anti-Venom doses if symptoms worsen or new ones develop.
- Keep the victim under medical monitoring for at least 24 hours even after symptoms resolve as delayed reactions can occur.
If given promptly by trained medical staff in the right doses, anti-venom is highly effective against the majority of venomous snake bites. Success rates of over 90% have been reported when Anti-Venom administration and additional supportive care is provided on time according to clinical protocols. However, some rare snakes may have unique venom components not neutralized by existing anti venoms.
Challenges in Global Anti-Venom Supply
While Anti-Venom has proven very effective in treating snake bites, there are still some major challenges in ensuring adequate global supplies:
- Limited production: Anti-Venom is complex to produce and not very profitable. Few manufacturers result in supply constraints.
- Distribution issues: Remote locations with highest snake bite burden often lack reliable infrastructure to transport and store Anti-Venom supplies.
- Funding gaps: Developing countries bear over 94% of the world's snake bite burden but have limited healthcare budgets for anti-venom.
- Lack of regulation: Substandard or expired Anti-Venom stocks still circulate in some areas resulting in treatment failures.
- Underreporting of cases: Actual number of snake bites remain underestimated due to underreporting impacting resource allocation.
Various organizations are now working to address issues like enhancing production capacities, improving distribution networks especially in tropical countries, promoting low-cost stable formulations, and advocating for more government support and funding. With a concerted effort, it may be possible to better control the global health challenge posed by snake bites.
Snake bite envenoming impacts millions of lives globally, especially rural agricultural communities in the tropics. While snake venom can be rapidly lethal, anti-venom remains among the most effective medical interventions ever developed if promptly administered by trained personnel. Further optimizing Anti-Venom supplies, access, and administration according to best practices can help minimize fatalities and disability from this common but neglected public health issue. With coordinated international efforts, the goals of ensuring adequate, affordable Anti-Venom availability worldwide seem achievable in the coming years.
Get this Report in Japanese Language
Get This Report in Korean Language
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)